Abstract:
The role of exposure to solvents was investigated in female patients with connective tissue disease and Raynaud’s phenomenon using a questionnaire. Sixteen out of the 63 patients with systemic sclerosis had been exposed to solvents. A borderline significance was demonstrated compared to matched female controls (P<0.05). Fourteen out of the 66 patients with undifferentiated connective tissue disease, 18/86 of patients with Raynaud’s phenomenon, 6/45 with systemic lupus erythematosus, 1/16 with dermatopolymyositis, 1/15 with rheumatoid arthritis and 0/13 with primary Sjögren’s syndrome had been exposed to solvents. None of these groups of patients showed a statistical significance compared to matched controls. Our present findings indicate that, at least in certain areas of the world, exposure to solvents may be a provoking factor in female scleroderma, but it must be emphasised that only a borderline significance was found between the scleroderma patients and controls. A large multicenter study seems to be required to clarify the importance of solvents as provoking factors of scleroderma. Furthermore, exposure to solvents does not seem to be a provoking factor among females for the other connective tissue diseases.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Additional information
Received: 3 January 2001 / Accepted: 18 September 2001
Rights and permissions
About this article
Cite this article
Czirják, L., Kumánovics, G. Exposure to Solvents in Female Patients with Scleroderma. Clin Rheumatol 21, 114–118 (2002). https://doi.org/10.1007/PL00011216
Published:
Issue Date:
DOI: https://doi.org/10.1007/PL00011216